MPX International Featured in a BBC Documentary on Canadian Cannabis Policy

Delegates visit Canveda Production Facilities and Hear Testimony from Veterans at Spartan Wellness as the UK Debates Cannabis Legalization

TORONTO, ON / ACCESSWIRE / July 31, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (CSE:MPXI)(OTC PINK:MPXOF) is pleased to announce that it was featured in a BBC Documentary “Legalising cannabis: Canada’s story” on July 29, 2019. The documentary received wide coverage on global BBC platforms and takes a look at the issues Canada grappled with prior to the legalization of cannabis and the impacts of legalization on the industry, the economy and society.

The documentary can be accessed at https://www.bbc.co.uk/news/av/newsbeat-49132155/legalising-cannabis-canada-s-story. It focuses on a group of UK delegates visiting Canada to see how its experience as the first G7 nation to legalize cannabis is panning out. MPXI’s partner, Volteface, a UK cross-party organization that informs the public debate around drugs through excellence in policy, research and advocacy, brought a cross-party delegation comprised of politicians, a charity, a think tank and members of the press to Toronto in June 2019.

“We are thrilled to be featured in this documentary, which brings greater awareness of the many positive impacts of cannabis legalization,” said W. Scott Boyes, Chairman, President and CEO of MPX International. “Jurisdictions around the world are grappling with whether to end prohibition and legalize the sale and possession of cannabis. Contributing to the conversation aligns with our mission to advance an ethical and sustainable global cannabis industry through our commitment to quality, innovation and improving lives.”

“Canada’s model enables the production of regulated, safer cannabis products and displaces unregulated, black market producers. Legalization also creates new job opportunities, drives tax revenues and reduces the strain on law enforcement by cutting out relatively petty cannabis-related crime, such as possession of small amounts of cannabis for personal use. We are seeing these benefits firsthand in Canada, and are pleased to see momentum for positive change also happening in other parts of the world,” concluded Mr. Boyes.

The three-day trip was organized so that delegates would gain a solid understanding of the issues and concerns that shaped Canadian policy before meeting with industry participants and front-line community workers to see first-hand the impacts of legalization.

With the support of MPX International, Volteface put together a program that ensured delegates left with a comprehensive understanding of the reasons for cannabis legalization, as well as knowledge of how Canada’s current legislation supports the emergence of a regulated industry, and the positive impact it has had on communities.

During the course of the trip, delegates visited MPX International’s wholly-owned subsidiary Canveda, which has a production facility in Peterborough Ontario. The delegates also heard testimony from Riad Byne and Dennis Leblanc, veterans whose lives have been turned around by medical cannabis and who now work at MPX International’s wholly-owned subsidiary Spartan Wellness, which supports veterans who wish to access medicinal cannabis.

About MPX International Corporation

MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

Cautionary Statement Regarding Forward-Looking Information

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, MPX International’s objectives and intentions. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those additional risks set out in MPX International’s public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although MPX International believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, MPX International disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

For further information, please contact:

MPX International Corporation
W. Scott Boyes, Chairman, President and CEO
T: +1-416-840-3725
info@mpxinternationalcorp.com
www.mpxinternationalcorp.com

SOURCE: MPX International Corporation

ReleaseID: 554082